Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese

Journal of Electrocardiology

Volumn 43, Issue 4, 2010, Pages 373-377

  Wang, Qun shan ^a   Li, Yi gang ^a   Chen, Xing dong ^b   Yu, Jie fei ^a   Wang, Jun ^a   Sun, Jian ^a   Lu, Shang biao ^a   Jin, Li ^b   Wang, Xiao feng ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Cardiac markers; Genetics; Polymorphism

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ARTICLE; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANGIOTENSINOGEN; ATRIAL FIBRILLATION; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RENIN; RISK ASSESSMENT; RISK FACTORS;

EID: 77953548845     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2009.09.009     Document Type: Article

References (26)

1. Feinberg W.M., Blackshear J.L., Laupacis A., et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155 (1995) 469
2. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA 285 (2001) 2370
3. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323 (1990) 1505
4. Kopecky S.L., Gersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 317 (1987) 669
5. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 41 (2003) 2185
6. Brugada R., Tapscott T., Czernuszewicz G.Z., et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 336 (1997) 905
7. Chen Y.H., Xu S.J., Bendahhou S., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299 (2003) 251
8. Yang Y., Xia M., Jin Q., et al. Identification of a kcne2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 75 (2004) 899
9. Hong K., Bjerregaard P., Gussak I., et al. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 16 (2005) 394
10. Gollob M.H., Jones D.L., Krahn A.D., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354 (2006) 2677
11. Lai L.P., Su M.J., Yeh H.M., et al. Association of the human mink gene 38g allele with atrial fibrillation: Evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 144 (2002) 485
12. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640
13. Goette A., Staack T., Rocken C., et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35 (2003) 1669
14. Nakashima H., Kumagai K., Urata H., et al. Angiotensin ii antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101 (2001) 2612
15. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263
16. Bell PA, Chaturvedi S, Gelfand CA, et al. Snpstream uht: Ultra-high throughput snp genotyping for pharmacogenomics and drug discovery. Biotechniques Suppl 2002; 70-72, 74, 76-77.
17. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978
18. Hahn L.W., Ritchie M.D., and Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19 (2003) 376
19. http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize.
20. Jain S., Tang X., Narayanan C.S., et al. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 277 (2002) 36889
21. Brand E., Chatelain N., Paillard F., et al. Detection of putative functional angiotensinogen (agt) gene variants controlling plasma agt levels by combined segregation-linkage analysis. Eur J Hum Genet 10 (2002) 715
22. Inoue I., Nakajima T., Williams C.S., et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99 (1997) 1786
23. Bloem L.J., Foroud T.M., Ambrosius W.T., et al. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 29 (1997) 1078
24. Agerholm-Larsen B., Tybjaerg-Hansen A., Schnohr P., et al. ACE gene polymorphism explains 30-40% of variability in serum ACE activity in both women and men in the population at large: the Copenhagen City Heart Study. Atherosclerosis 147 (1999) 425
25. Gudbjartsson D.F., Arnar D.O., Helgadottir A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448 (2007) 353
26. Mommersteeg M.T., Hoogaars W.M., Prall O.W., et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 100 (2007) 354